Chargement en cours...
Pristimerin inhibits the proliferation of HT1080 fibrosarcoma cells by inducing apoptosis
Fibrosarcoma is a soft tissue sarcoma that is classified as a rare cancer. Therefore, no standard anti-tumor drug therapy has been established for fibrosarcoma. Although pristimerin (PM) has been reported to exert an anti-tumor effect on various types of cancer, no studies have examined the therapeu...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068646/ https://ncbi.nlm.nih.gov/pubmed/32218852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11405 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|